Global Primary Biliary Cirrhosis Drug Sales Market Report 2021

Global Primary Biliary Cirrhosis Drug Sales Market Report 2021

Table of Contents
1 Primary Biliary Cirrhosis Drug Market Overview
1.1 Primary Biliary Cirrhosis Drug Product Scope
1.2 Primary Biliary Cirrhosis Drug Segment by Type
1.2.1 Global Primary Biliary Cirrhosis Drug Sales by Type (2016 & 2021 & 2027)
1.2.2 Budesonide
1.2.3 FFP-104
1.2.4 GSK-2330672
1.2.5 MBX-8025
1.2.6 NGM-282
1.2.7 Others
1.3 Primary Biliary Cirrhosis Drug Segment by Application
1.3.1 Global Primary Biliary Cirrhosis Drug Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Primary Biliary Cirrhosis Drug Market Estimates and Forecasts (2016-2027)
1.4.1 Global Primary Biliary Cirrhosis Drug Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Primary Biliary Cirrhosis Drug Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Primary Biliary Cirrhosis Drug Price Trends (2016-2027)
2 Primary Biliary Cirrhosis Drug Estimates and Forecasts by Region
2.1 Global Primary Biliary Cirrhosis Drug Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Primary Biliary Cirrhosis Drug Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Primary Biliary Cirrhosis Drug Sales Market Share by Region (2016-2021)
2.2.2 Global Primary Biliary Cirrhosis Drug Revenue Market Share by Region (2016-2021)
2.3 Global Primary Biliary Cirrhosis Drug Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Primary Biliary Cirrhosis Drug Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Primary Biliary Cirrhosis Drug Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Primary Biliary Cirrhosis Drug Estimates and Projections (2016-2027)
2.4.2 Europe Primary Biliary Cirrhosis Drug Estimates and Projections (2016-2027)
2.4.3 China Primary Biliary Cirrhosis Drug Estimates and Projections (2016-2027)
2.4.4 Japan Primary Biliary Cirrhosis Drug Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Primary Biliary Cirrhosis Drug Estimates and Projections (2016-2027)
2.4.6 India Primary Biliary Cirrhosis Drug Estimates and Projections (2016-2027)
3 Global Primary Biliary Cirrhosis Drug Competition Landscape by Players
3.1 Global Top Primary Biliary Cirrhosis Drug Players by Sales (2016-2021)
3.2 Global Top Primary Biliary Cirrhosis Drug Players by Revenue (2016-2021)
3.3 Global Primary Biliary Cirrhosis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Primary Biliary Cirrhosis Drug as of 2020)
3.4 Global Primary Biliary Cirrhosis Drug Average Price by Company (2016-2021)
3.5 Manufacturers Primary Biliary Cirrhosis Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Primary Biliary Cirrhosis Drug Market Size by Type
4.1 Global Primary Biliary Cirrhosis Drug Historic Market Review by Type (2016-2021)
4.1.1 Global Primary Biliary Cirrhosis Drug Sales Market Share by Type (2016-2021)
4.1.2 Global Primary Biliary Cirrhosis Drug Revenue Market Share by Type (2016-2021)
4.1.3 Global Primary Biliary Cirrhosis Drug Price by Type (2016-2021)
4.2 Global Primary Biliary Cirrhosis Drug Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Primary Biliary Cirrhosis Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Primary Biliary Cirrhosis Drug Revenue Forecast by Type (2022-2027)
4.2.3 Global Primary Biliary Cirrhosis Drug Price Forecast by Type (2022-2027)
5 Global Primary Biliary Cirrhosis Drug Market Size by Application
5.1 Global Primary Biliary Cirrhosis Drug Historic Market Review by Application (2016-2021)
5.1.1 Global Primary Biliary Cirrhosis Drug Sales Market Share by Application (2016-2021)
5.1.2 Global Primary Biliary Cirrhosis Drug Revenue Market Share by Application (2016-2021)
5.1.3 Global Primary Biliary Cirrhosis Drug Price by Application (2016-2021)
5.2 Global Primary Biliary Cirrhosis Drug Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Primary Biliary Cirrhosis Drug Sales Forecast by Application (2022-2027)
5.2.2 Global Primary Biliary Cirrhosis Drug Revenue Forecast by Application (2022-2027)
5.2.3 Global Primary Biliary Cirrhosis Drug Price Forecast by Application (2022-2027)
6 North America Primary Biliary Cirrhosis Drug Market Facts & Figures
6.1 North America Primary Biliary Cirrhosis Drug Sales by Company
6.1.1 North America Primary Biliary Cirrhosis Drug Sales by Company (2016-2021)
6.1.2 North America Primary Biliary Cirrhosis Drug Revenue by Company (2016-2021)
6.2 North America Primary Biliary Cirrhosis Drug Sales Breakdown by Type
6.2.1 North America Primary Biliary Cirrhosis Drug Sales Breakdown by Type (2016-2021)
6.2.2 North America Primary Biliary Cirrhosis Drug Sales Breakdown by Type (2022-2027)
6.3 North America Primary Biliary Cirrhosis Drug Sales Breakdown by Application
6.3.1 North America Primary Biliary Cirrhosis Drug Sales Breakdown by Application (2016-2021)
6.3.2 North America Primary Biliary Cirrhosis Drug Sales Breakdown by Application (2022-2027)
7 Europe Primary Biliary Cirrhosis Drug Market Facts & Figures
7.1 Europe Primary Biliary Cirrhosis Drug Sales by Company
7.1.1 Europe Primary Biliary Cirrhosis Drug Sales by Company (2016-2021)
7.1.2 Europe Primary Biliary Cirrhosis Drug Revenue by Company (2016-2021)
7.2 Europe Primary Biliary Cirrhosis Drug Sales Breakdown by Type
7.2.1 Europe Primary Biliary Cirrhosis Drug Sales Breakdown by Type (2016-2021)
7.2.2 Europe Primary Biliary Cirrhosis Drug Sales Breakdown by Type (2022-2027)
7.3 Europe Primary Biliary Cirrhosis Drug Sales Breakdown by Application
7.3.1 Europe 134 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 134 Sales Breakdown by Application (2022-2027)
8 China Primary Biliary Cirrhosis Drug Market Facts & Figures
8.1 China Primary Biliary Cirrhosis Drug Sales by Company
8.1.1 China Primary Biliary Cirrhosis Drug Sales by Company (2016-2021)
8.1.2 China Primary Biliary Cirrhosis Drug Revenue by Company (2016-2021)
8.2 China Primary Biliary Cirrhosis Drug Sales Breakdown by Type
8.2.1 China Primary Biliary Cirrhosis Drug Sales Breakdown by Type (2016-2021)
8.2.2 China Primary Biliary Cirrhosis Drug Sales Breakdown by Type (2022-2027)
8.3 China Primary Biliary Cirrhosis Drug Sales Breakdown by Application
8.3.1 China 157 Sales Breakdown by Application (2016-2021)
8.3.2 China 157 Sales Breakdown by Application (2022-2027)
9 Japan Primary Biliary Cirrhosis Drug Market Facts & Figures
9.1 Japan Primary Biliary Cirrhosis Drug Sales by Company
9.1.1 Japan Primary Biliary Cirrhosis Drug Sales by Company (2016-2021)
9.1.2 Japan Primary Biliary Cirrhosis Drug Revenue by Company (2016-2021)
9.2 Japan Primary Biliary Cirrhosis Drug Sales Breakdown by Type
9.2.1 Japan Primary Biliary Cirrhosis Drug Sales Breakdown by Type (2016-2021)
9.2.2 Japan Primary Biliary Cirrhosis Drug Sales Breakdown by Type (2022-2027)
9.3 Japan Primary Biliary Cirrhosis Drug Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Primary Biliary Cirrhosis Drug Market Facts & Figures
10.1 Southeast Asia Primary Biliary Cirrhosis Drug Sales by Company
10.1.1 Southeast Asia Primary Biliary Cirrhosis Drug Sales by Company (2016-2021)
10.1.2 Southeast Asia Primary Biliary Cirrhosis Drug Revenue by Company (2016-2021)
10.2 Southeast Asia Primary Biliary Cirrhosis Drug Sales Breakdown by Type
10.2.1 Southeast Asia Primary Biliary Cirrhosis Drug Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Primary Biliary Cirrhosis Drug Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Primary Biliary Cirrhosis Drug Sales Breakdown by Application
10.3.1 Southeast Asia K Pcs Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Pcs Sales Breakdown by Application (2022-2027)
11 India Primary Biliary Cirrhosis Drug Market Facts & Figures
11.1 India Primary Biliary Cirrhosis Drug Sales by Company
11.1.1 India Primary Biliary Cirrhosis Drug Sales by Company (2016-2021)
11.1.2 India Primary Biliary Cirrhosis Drug Revenue by Company (2016-2021)
11.2 India Primary Biliary Cirrhosis Drug Sales Breakdown by Type
11.2.1 India Primary Biliary Cirrhosis Drug Sales Breakdown by Type (2016-2021)
11.2.2 India Primary Biliary Cirrhosis Drug Sales Breakdown by Type (2022-2027)
11.3 India Primary Biliary Cirrhosis Drug Sales Breakdown by Application
11.3.1 India Primary Biliary Cirrhosis Drug Sales Breakdown by Application (2016-2021)
11.3.2 India Primary Biliary Cirrhosis Drug Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Primary Biliary Cirrhosis Drug Business
12.1 AlbireoPharma
12.1.1 AlbireoPharma Corporation Information
12.1.2 AlbireoPharma Business Overview
12.1.3 AlbireoPharma Primary Biliary Cirrhosis Drug Sales, Revenue and Gross Margin (2016-2021)
12.1.4 AlbireoPharma Primary Biliary Cirrhosis Drug Products Offered
12.1.5 AlbireoPharma Recent Development
12.2 CymaBay Therapeutics, Inc.
12.2.1 CymaBay Therapeutics, Inc. Corporation Information
12.2.2 CymaBay Therapeutics, Inc. Business Overview
12.2.3 CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Sales, Revenue and Gross Margin (2016-2021)
12.2.4 CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Products Offered
12.2.5 CymaBay Therapeutics, Inc. Recent Development
12.3 Dr. Falk Pharma GmbH
12.3.1 Dr. Falk Pharma GmbH Corporation Information
12.3.2 Dr. Falk Pharma GmbH Business Overview
12.3.3 Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Products Offered
12.3.5 Dr. Falk Pharma GmbH Recent Development
12.4 Enanta Pharmaceuticals, Inc.
12.4.1 Enanta Pharmaceuticals, Inc. Corporation Information
12.4.2 Enanta Pharmaceuticals, Inc. Business Overview
12.4.3 Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Products Offered
12.4.5 Enanta Pharmaceuticals, Inc. Recent Development
12.5 GlaxoSmithKline Plc
12.5.1 GlaxoSmithKline Plc Corporation Information
12.5.2 GlaxoSmithKline Plc Business Overview
12.5.3 GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Sales, Revenue and Gross Margin (2016-2021)
12.5.4 GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Products Offered
12.5.5 GlaxoSmithKline Plc Recent Development
12.6 Intercept Pharmaceuticals, Inc.
12.6.1 Intercept Pharmaceuticals, Inc. Corporation Information
12.6.2 Intercept Pharmaceuticals, Inc. Business Overview
12.6.3 Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Products Offered
12.6.5 Intercept Pharmaceuticals, Inc. Recent Development
12.7 Johnson & Johnson
12.7.1 Johnson & Johnson Corporation Information
12.7.2 Johnson & Johnson Business Overview
12.7.3 Johnson & Johnson Primary Biliary Cirrhosis Drug Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Johnson & Johnson Primary Biliary Cirrhosis Drug Products Offered
12.7.5 Johnson & Johnson Recent Development
12.8 MediGene AG
12.8.1 MediGene AG Corporation Information
12.8.2 MediGene AG Business Overview
12.8.3 MediGene AG Primary Biliary Cirrhosis Drug Sales, Revenue and Gross Margin (2016-2021)
12.8.4 MediGene AG Primary Biliary Cirrhosis Drug Products Offered
12.8.5 MediGene AG Recent Development
12.9 NGM Biopharmaceuticals, Inc.
12.9.1 NGM Biopharmaceuticals, Inc. Corporation Information
12.9.2 NGM Biopharmaceuticals, Inc. Business Overview
12.9.3 NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales, Revenue and Gross Margin (2016-2021)
12.9.4 NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Products Offered
12.9.5 NGM Biopharmaceuticals, Inc. Recent Development
12.10 Virobay Inc.
12.10.1 Virobay Inc. Corporation Information
12.10.2 Virobay Inc. Business Overview
12.10.3 Virobay Inc. Primary Biliary Cirrhosis Drug Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Virobay Inc. Primary Biliary Cirrhosis Drug Products Offered
12.10.5 Virobay Inc. Recent Development
13 Primary Biliary Cirrhosis Drug Manufacturing Cost Analysis
13.1 Primary Biliary Cirrhosis Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Primary Biliary Cirrhosis Drug
13.4 Primary Biliary Cirrhosis Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Primary Biliary Cirrhosis Drug Distributors List
14.3 Primary Biliary Cirrhosis Drug Customers
15 Market Dynamics
15.1 Primary Biliary Cirrhosis Drug Market Trends
15.2 Primary Biliary Cirrhosis Drug Drivers
15.3 Primary Biliary Cirrhosis Drug Market Challenges
15.4 Primary Biliary Cirrhosis Drug Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
Table 1. Global Primary Biliary Cirrhosis Drug Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Primary Biliary Cirrhosis Drug Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Primary Biliary Cirrhosis Drug Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Primary Biliary Cirrhosis Drug Sales (K Pcs) by Region (2016-2021)
Table 5. Global Primary Biliary Cirrhosis Drug Sales Market Share by Region (2016-2021)
Table 6. Global Primary Biliary Cirrhosis Drug Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Primary Biliary Cirrhosis Drug Revenue Share by Region (2016-2021)
Table 8. Global Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by Region (2022-2027)
Table 9. Global Primary Biliary Cirrhosis Drug Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Primary Biliary Cirrhosis Drug Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Primary Biliary Cirrhosis Drug Revenue Share Forecast by Region (2022-2027)
Table 12. Global Primary Biliary Cirrhosis Drug Sales (K Pcs) of Key Companies (2016-2021)
Table 13. Global Primary Biliary Cirrhosis Drug Sales Share by Company (2016-2021)
Table 14. Global Primary Biliary Cirrhosis Drug Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Primary Biliary Cirrhosis Drug Revenue Share by Company (2016-2021)
Table 16. Global Primary Biliary Cirrhosis Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Primary Biliary Cirrhosis Drug as of 2020)
Table 17. Global Primary Biliary Cirrhosis Drug Average Price (USD/Pcs) of Key Company (2016-2021)
Table 18. Manufacturers Primary Biliary Cirrhosis Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Primary Biliary Cirrhosis Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Primary Biliary Cirrhosis Drug Sales (K Pcs) by Type (2016-2021)
Table 22. Global Primary Biliary Cirrhosis Drug Sales Share by Type (2016-2021)
Table 23. Global Primary Biliary Cirrhosis Drug Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Primary Biliary Cirrhosis Drug Price (USD/Pcs) by Type (2016-2021)
Table 25. Global Primary Biliary Cirrhosis Drug Sales Share by Type (2022-2027)
Table 26. Global Primary Biliary Cirrhosis Drug Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Primary Biliary Cirrhosis Drug Revenue Share by Type (2022-2027)
Table 28. Global Primary Biliary Cirrhosis Drug Price (USD/Pcs) by Type (2022-2027)
Table 29. Global Primary Biliary Cirrhosis Drug Sales (K Pcs) by Application (2016-2021)
Table 30. Global Primary Biliary Cirrhosis Drug Sales Share by Application (2016-2021)
Table 31. Global Primary Biliary Cirrhosis Drug Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Primary Biliary Cirrhosis Drug Price (USD/Pcs) by Application (2016-2021)
Table 33. Global Primary Biliary Cirrhosis Drug Sales (K Pcs) by Application (2022-2027)
Table 34. Global Primary Biliary Cirrhosis Drug Sales Share by Application (2022-2027)
Table 35. Global Primary Biliary Cirrhosis Drug Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Primary Biliary Cirrhosis Drug Revenue Share by Application (2022-2027)
Table 37. Global Primary Biliary Cirrhosis Drug Price (USD/Pcs) by Application (2022-2027)
Table 38. North America Primary Biliary Cirrhosis Drug Sales (K Pcs) by Company (2016-2021)
Table 39. North America Primary Biliary Cirrhosis Drug Sales Market Share by Company (2016-2021)
Table 40. North America Primary Biliary Cirrhosis Drug Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Primary Biliary Cirrhosis Drug Revenue Market Share by Company (2016-2021)
Table 42. North America Primary Biliary Cirrhosis Drug Sales by Type (2016-2021) & (K Pcs)
Table 43. North America Primary Biliary Cirrhosis Drug Sales Market Share by Type (2016-2021)
Table 44. North America Primary Biliary Cirrhosis Drug Sales by Type (2022-2027) & (K Pcs)
Table 45. North America Primary Biliary Cirrhosis Drug Sales Market Share by Type (2022-2027)
Table 46. North America Primary Biliary Cirrhosis Drug Sales by Application (2016-2021) & (K Pcs)
Table 47. North America Primary Biliary Cirrhosis Drug Sales Market Share by Application (2016-2021)
Table 48. North America Primary Biliary Cirrhosis Drug Sales by Application (2022-2027) & (K Pcs)
Table 49. North America Primary Biliary Cirrhosis Drug Sales Market Share by Application (2022-2027)
Table 50. Europe Primary Biliary Cirrhosis Drug Sales (K Pcs) by Company (2016-2021)
Table 51. Europe Primary Biliary Cirrhosis Drug Sales Market Share by Company (2016-2021)
Table 52. Europe Primary Biliary Cirrhosis Drug Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Primary Biliary Cirrhosis Drug Revenue Market Share by Company (2016-2021)
Table 54. Europe Primary Biliary Cirrhosis Drug Sales by Type (2016-2021) & (K Pcs)
Table 55. Europe Primary Biliary Cirrhosis Drug Sales Market Share by Type (2016-2021)
Table 56. Europe Primary Biliary Cirrhosis Drug Sales by Type (2022-2027) & (K Pcs)
Table 57. Europe Primary Biliary Cirrhosis Drug Sales Market Share by Type (2022-2027)
Table 58. Europe Primary Biliary Cirrhosis Drug Sales by Application (2016-2021) & (K Pcs)
Table 59. Europe Primary Biliary Cirrhosis Drug Sales Market Share by Application (2016-2021)
Table 60. Europe Primary Biliary Cirrhosis Drug Sales by Application (2022-2027) & (K Pcs)
Table 61. Europe Primary Biliary Cirrhosis Drug Sales Market Share by Application (2022-2027)
Table 62. China Primary Biliary Cirrhosis Drug Sales (K Pcs) by Company (2016-2021)
Table 63. China Primary Biliary Cirrhosis Drug Sales Market Share by Company (2016-2021)
Table 64. China Primary Biliary Cirrhosis Drug Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Primary Biliary Cirrhosis Drug Revenue Market Share by Company (2016-2021)
Table 66. China Primary Biliary Cirrhosis Drug Sales by Type (2016-2021) & (K Pcs)
Table 67. China Primary Biliary Cirrhosis Drug Sales Market Share by Type (2016-2021)
Table 68. China Primary Biliary Cirrhosis Drug Sales by Type (2022-2027) & (K Pcs)
Table 69. China Primary Biliary Cirrhosis Drug Sales Market Share by Type (2022-2027)
Table 70. China Primary Biliary Cirrhosis Drug Sales by Application (2016-2021) & (K Pcs)
Table 71. China Primary Biliary Cirrhosis Drug Sales Market Share by Application (2016-2021)
Table 72. China Primary Biliary Cirrhosis Drug Sales by Application (2022-2027) & (K Pcs)
Table 73. China Primary Biliary Cirrhosis Drug Sales Market Share by Application (2022-2027)
Table 74. Japan Primary Biliary Cirrhosis Drug Sales (K Pcs) by Company (2016-2021)
Table 75. Japan Primary Biliary Cirrhosis Drug Sales Market Share by Company (2016-2021)
Table 76. Japan Primary Biliary Cirrhosis Drug Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Primary Biliary Cirrhosis Drug Revenue Market Share by Company (2016-2021)
Table 78. Japan Primary Biliary Cirrhosis Drug Sales by Type (2016-2021) & (K Pcs)
Table 79. Japan Primary Biliary Cirrhosis Drug Sales Market Share by Type (2016-2021)
Table 80. Japan Primary Biliary Cirrhosis Drug Sales by Type (2022-2027) & (K Pcs)
Table 81. Japan Primary Biliary Cirrhosis Drug Sales Market Share by Type (2022-2027)
Table 82. Japan Primary Biliary Cirrhosis Drug Sales by Application (2016-2021) & (K Pcs)
Table 83. Japan Primary Biliary Cirrhosis Drug Sales Market Share by Application (2016-2021)
Table 84. Japan Primary Biliary Cirrhosis Drug Sales by Application (2022-2027) & (K Pcs)
Table 85. Japan Primary Biliary Cirrhosis Drug Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Primary Biliary Cirrhosis Drug Sales (K Pcs) by Company (2016-2021)
Table 87. Southeast Asia Primary Biliary Cirrhosis Drug Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Primary Biliary Cirrhosis Drug Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Primary Biliary Cirrhosis Drug Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Primary Biliary Cirrhosis Drug Sales by Type (2016-2021) & (K Pcs)
Table 91. Southeast Asia Primary Biliary Cirrhosis Drug Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Primary Biliary Cirrhosis Drug Sales by Type (2022-2027) & (K Pcs)
Table 93. Southeast Asia Primary Biliary Cirrhosis Drug Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Primary Biliary Cirrhosis Drug Sales by Application (2016-2021) & (K Pcs)
Table 95. Southeast Asia Primary Biliary Cirrhosis Drug Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Primary Biliary Cirrhosis Drug Sales by Application (2022-2027) & (K Pcs)
Table 97. Southeast Asia Primary Biliary Cirrhosis Drug Sales Market Share by Application (2022-2027)
Table 98. India Primary Biliary Cirrhosis Drug Sales (K Pcs) by Company (2016-2021)
Table 99. India Primary Biliary Cirrhosis Drug Sales Market Share by Company (2016-2021)
Table 100. India Primary Biliary Cirrhosis Drug Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Primary Biliary Cirrhosis Drug Revenue Market Share by Company (2016-2021)
Table 102. India Primary Biliary Cirrhosis Drug Sales by Type (2016-2021) & (K Pcs)
Table 103. India Primary Biliary Cirrhosis Drug Sales Market Share by Type (2016-2021)
Table 104. India Primary Biliary Cirrhosis Drug Sales by Type (2022-2027) & (K Pcs)
Table 105. India Primary Biliary Cirrhosis Drug Sales Market Share by Type (2022-2027)
Table 106. India Primary Biliary Cirrhosis Drug Sales by Application (2016-2021) & (K Pcs)
Table 107. India Primary Biliary Cirrhosis Drug Sales Market Share by Application (2016-2021)
Table 108. India Primary Biliary Cirrhosis Drug Sales by Application (2022-2027) & (K Pcs)
Table 109. India Primary Biliary Cirrhosis Drug Sales Market Share by Application (2022-2027)
Table 110. AlbireoPharma Corporation Information
Table 111. AlbireoPharma Description and Business Overview
Table 112. AlbireoPharma Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 113. AlbireoPharma Primary Biliary Cirrhosis Drug Product
Table 114. AlbireoPharma Recent Development
Table 115. CymaBay Therapeutics, Inc. Corporation Information
Table 116. CymaBay Therapeutics, Inc. Description and Business Overview
Table 117. CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 118. CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Product
Table 119. CymaBay Therapeutics, Inc. Recent Development
Table 120. Dr. Falk Pharma GmbH Corporation Information
Table 121. Dr. Falk Pharma GmbH Description and Business Overview
Table 122. Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 123. Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Product
Table 124. Dr. Falk Pharma GmbH Recent Development
Table 125. Enanta Pharmaceuticals, Inc. Corporation Information
Table 126. Enanta Pharmaceuticals, Inc. Description and Business Overview
Table 127. Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 128. Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Product
Table 129. Enanta Pharmaceuticals, Inc. Recent Development
Table 130. GlaxoSmithKline Plc Corporation Information
Table 131. GlaxoSmithKline Plc Description and Business Overview
Table 132. GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 133. GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Product
Table 134. GlaxoSmithKline Plc Recent Development
Table 135. Intercept Pharmaceuticals, Inc. Corporation Information
Table 136. Intercept Pharmaceuticals, Inc. Description and Business Overview
Table 137. Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 138. Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Product
Table 139. Intercept Pharmaceuticals, Inc. Recent Development
Table 140. Johnson & Johnson Corporation Information
Table 141. Johnson & Johnson Description and Business Overview
Table 142. Johnson & Johnson Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 143. Johnson & Johnson Primary Biliary Cirrhosis Drug Product
Table 144. Johnson & Johnson Recent Development
Table 145. MediGene AG Corporation Information
Table 146. MediGene AG Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 147. MediGene AG Description and Business Overview
Table 148. MediGene AG Primary Biliary Cirrhosis Drug Product
Table 149. MediGene AG Recent Development
Table 150. NGM Biopharmaceuticals, Inc. Corporation Information
Table 151. NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 152. NGM Biopharmaceuticals, Inc. Description and Business Overview
Table 153. NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Product
Table 154. NGM Biopharmaceuticals, Inc. Recent Development
Table 155. Virobay Inc. Corporation Information
Table 156. Virobay Inc. Description and Business Overview
Table 157. Virobay Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 158. Virobay Inc. Primary Biliary Cirrhosis Drug Product
Table 159. Virobay Inc. Recent Development
Table 160. Production Base and Market Concentration Rate of Raw Material
Table 161. Key Suppliers of Raw Materials
Table 162. Primary Biliary Cirrhosis Drug Distributors List
Table 163. Primary Biliary Cirrhosis Drug Customers List
Table 164. Primary Biliary Cirrhosis Drug Market Trends
Table 165. Primary Biliary Cirrhosis Drug Market Drivers
Table 166. Primary Biliary Cirrhosis Drug Market Challenges
Table 167. Primary Biliary Cirrhosis Drug Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Primary Biliary Cirrhosis Drug Product Picture
Figure 2. Global Primary Biliary Cirrhosis Drug Sales Market Share by Type in 2021 & 2027
Figure 3. Budesonide Product Picture
Figure 4. FFP-104 Product Picture
Figure 5. GSK-2330672 Product Picture
Figure 6. MBX-8025 Product Picture
Figure 7. NGM-282 Product Picture
Figure 8. Others Product Picture
Figure 9. Global Primary Biliary Cirrhosis Drug Sales Market Share by Application in 2021 & 2027
Figure 10. Clinic Examples
Figure 11. Hospital Examples
Figure 12. Others Examples
Figure 13. Global Primary Biliary Cirrhosis Drug Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Primary Biliary Cirrhosis Drug Sales Growth Rate (2016-2027) & (US$ Million)
Figure 15. Global Primary Biliary Cirrhosis Drug Sales (K Pcs) Growth Rate (2016-2027)
Figure 16. Global Primary Biliary Cirrhosis Drug Price Trends Growth Rate (2016-2027) (USD/Pcs)
Figure 17. Global Primary Biliary Cirrhosis Drug Revenue Market Share by Region: 2016 VS 2021
Figure 18. Global Primary Biliary Cirrhosis Drug Revenue Market Share by Region: 2021 VS 2027
Figure 19. North America Primary Biliary Cirrhosis Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. North America Primary Biliary Cirrhosis Drug Sales (K Pcs) Growth Rate (2016-2027)
Figure 21. Europe Primary Biliary Cirrhosis Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Europe Primary Biliary Cirrhosis Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 23. China Primary Biliary Cirrhosis Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. China Primary Biliary Cirrhosis Drug Sales (Million USD) and Growth Rate (2016-2027)
Figure 25. Japan Primary Biliary Cirrhosis Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. Japan Primary Biliary Cirrhosis Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Southeast Asia Primary Biliary Cirrhosis Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 28. Southeast Asia Primary Biliary Cirrhosis Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 29. India Primary Biliary Cirrhosis Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 30. India Primary Biliary Cirrhosis Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 31. Global 5 Largest Primary Biliary Cirrhosis Drug Players Market Share by Revenue in Primary Biliary Cirrhosis Drug: 2016 & 2020
Figure 32. Primary Biliary Cirrhosis Drug Market Share by

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87

The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......

Global Esomeprazole Magnesium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74

The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......

Global Combination Therapy Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......

Global Axitinib Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68

The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......

Global Lyme Disease Vaccine Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70

The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......

Global Transdermal Absorption Patch Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......

Global Ketoprofen Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......

Global Methyl Salicylate Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82

The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......

Global Diclofenac Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs